Influencing factors of early objective response of unresectable hepatitis B virus⁃related liver cancer with triple therapy
Objective To explore the factors associated with achieving early objective response in patients with unresectable hepatitis B virus(HBV)⁃related liver cancer after three months of triple therapy,including transcatheter arterial chemoembolization(TACE),lenvatinib,and programmed death receptor⁃ 1(PD⁃1...
Saved in:
| Main Author: | YU Jin*,LI Xiaogang |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
The Editorial Department of Chinese Journal of Clinical Research
2025-08-01
|
| Series: | Zhongguo linchuang yanjiu |
| Subjects: | |
| Online Access: | http://zglcyj.ijournals.cn/zglcyj/ch/reader/create_pdf.aspx?file_no=20250815 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy Analysis of TACE Combined with Lenvatinib and PD-1 Inhibitors in the Treatment of Hepatitis B Virus-Related Unresectable Hepatocellular Carcinoma
by: Yu J, et al.
Published: (2025-07-01) -
ENDOVASCULAR CHEMOEMBOLIZATION OF THE HEPATIC ARTERY - A MODERN METHOD OF LOCAL CHEMOTHERAPY OF MALIGNANT LIVER LESIONS
by: V. E. Zagaynov, et al.
Published: (2017-04-01) -
CASE OF TREATMENT OF UNRESECTABLE HEPATOCELLULAR CARCINOMA OF THE LIVER THROUGH THE HEPATIC ARTERY CHEMOEMBOLIZATION M
by: A. I. Gritsaenko, et al.
Published: (2017-01-01) -
Dual-drug loaded chondroitin sulfate embolization beads enhance TACE therapy for HCC by integrating embolization, chemotherapy, and anti-angiogenesis
by: Jin-Xin Huang, et al.
Published: (2025-02-01) -
Efficacy and Safety of Transcatheter Arterial Chemoembolization Combined with Lenvatinib Plus Anti-PD-1 Inhibitors for Hepatocellular Carcinoma Patients with Extrahepatic Metastases: A Multicenter Retrospective Study
by: Liu DY, et al.
Published: (2024-11-01)